Open AccessDecreased risk of cholangiocarcinoma in diabetic patients treated with metformin
Author(s) -
Pathum Sookaromdee,
Viroj Wiwanitkit
Publication year - 2020
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_368_18
Subject(s) - metformin , medicine , diabetes mellitus , biliary tract cancer , cancer , incidence (geometry) , pancreatic cancer , oncology , gastroenterology , endocrinology , physics , gemcitabine , optics
Cholangiocarcinoma is an important biliary tract cancer. The high incidence of this cancer is observed in tropical Asia. Several underlying factors are mentioned for this cancer including to diabetes mellitus. The use of the antidiabetic drug, metformin, is mentioned for possibility for decreasing risk for cholangiocarcinoma.